Transactions
The value of everything
In 2024, there were around 13,000 deals announced in the TMT sector worldwide with a total deal value of around $800 billion. However, are businesses buying innovators to achieve their technology development needs or are they preferring to collaborate to get ahead of the market? Collaborations for innovation, over acquisitions, are not new but we have seen the numbers increase in the last few years and they show no signs of slowing down in 2025. The rate of increase is more prevalent in sectors which are being disrupted by technology, for example, the renewable energy and drug discovery/screening sectors – collaborations in these sectors are increasing by number, value and complexity.
For example, in 2024, amongst the many pioneering collaborations, we saw OpenAI and Apple announce a partnership to integrate ChatGPT into Apple experiences, and Telefónica Tech and IBM announce a collaboration for AI analytics and data governance solutions. On the med-tech side, Novartis and the Generate:Biomedicines company announced a partnership together worth more than $1 billion to develop protein therapeutics across multiple indications, Bayer announced a collaboration with software group Alara Imaging to standardise radiation doses used in computed tomography scans, and Novartis announced a collaboration with drug delivery specialist Lindy Biosciences to develop drug technology for self-administering (which gives Lindy the opportunity to secure nearly $1 billion in milestone payments).
The continued popularity of collaborations is driven by a number of important factors. Collaborations can give a party access to new markets, customers, finance and, critically, valuable intellectual property (IP).
Ongoing innovation – One key advantage of collaborations, over acquisitions, is ongoing innovation throughout the lifetime of the collaboration, with parties having the opportunity to pool their resources, IP and know-how into research and development work. Collaborations are also useful in enabling a party to break into a new territory or a risky market, taking advantage of the other party's reputation or experience or size in that territory or market. Collaborations often involve licences of IP, which give the non-owning party the right to use the owner's IP on the agreed terms. Further, collaborations often involve parties providing associated support to each other in their area of expertise.
Regulatory issues – Regulatory considerations also drive decisions to pursue collaborations over acquisitions. Collaborations generally encounter fewer regulatory hurdles, such as data transfer regulations and competition law scrutiny. In today's dynamic geopolitical landscape, collaborations provide greater flexibility in cross-border transactions, helping parties navigate trade controls like export or import restrictions on technology. For instance, being a minority shareholder in a joint venture can sometimes enable a company to access otherwise unreachable technology and markets without facing stringent export control restrictions.
Commercials – Collaborations and IP licensing offer more flexible and innovative pricing models than acquisitions, which typically involves ongoing payments such as licensing fees, milestone payments, and royalties. The pricing models can allow the licensor party to generate a continuous revenue stream from underutilised assets while retaining ownership of such assets for its own strategic use. This flexible approach is particularly advantageous for early-stage technology where the full potential of the technology is still being explored. In contrast, acquisitions usually involve a one-time, upfront payment (often based on speculative future usefulness of the IP), granting the acquiring company full control over the IP. While this method can be more straightforward, it often comes with higher initial costs and complex tax implications. Additionally, collaborations may be eligible for grants or other incentives that are not available in acquisitions.
Comfort on technology – A clear understanding of the IP considerations in the technology being used and generated provides the foundation for successful collaborations. While the technology may work perfectly for the licensor party, the licensee party must ensure it meets their specific needs, whether in a different market or for different purposes, and determine if modifications are necessary. The consequences of the technology failing to meet agreed-upon specifications are highly negotiated. Parties should agree on the scope of performance and IP warranties and include provisions for remedies. From the licensor party's perspective, it is crucial to clearly define the scope of these warranties and indemnities to avoid excessive exposure. For example, indemnities should exclude scenarios where the licensee party uses the technology for unauthorised purposes, makes unauthorised modifications, or combines it with third-party technologies.
Project improvements – New IP may emerge and it is critical that this is identified (and registered where necessary) and it is agreed who will own it and how the parties can use this new IP going forward. This is key for avoiding disputes following any successful conclusion of a collaboration, and even more so if the collaboration terminates unexpectedly. Consideration of confidential information is also critical, as the parties will be sharing their confidential/commercially sensitive information at an early stage. Newly created IP in the collaboration may take the form of confidential information/know-how/trade secrets. The success of the collaboration may therefore depend on ensuring the information is kept secret. Contractual and internal arrangements should protect against the release or misuse of this information.
Ongoing relationship – Compared to technology acquisitions, where the IP is usually acquired outright and the parties enjoy a "clean break" post completion of the transaction, collaborations rely on the parties' continued cooperation, often for a significant period of time. We are also seeing an increased interest on collaboration follow-ons, where the same parties collaborate on new projects, which can be related or unrelated to their previous project. The appetite for follow-ons depends on the success of the initial collaboration and the relationship between the parties during the collaboration life-cycle.
Exit arrangements – Long-term collaborations can sometimes turn sour as parties' goals and priorities shift over time. It is crucial to clearly define termination triggers and their effects. Parties should align on common termination concepts such as what constitutes a "material" breach and change of control, as well as bespoke triggers like unachieved milestones. A well-thought-out exit plan is essential to ensure a smooth break-up, which should address matters such as whether a party can continue to use certain technology or data owned by the other party (and, if so, on what terms) and whether a party requires transitional services to minimise disruption to its operations (and, if so, on what terms).
Disputes – In collaborations, we often see that arbitration is the agreed dispute resolution procedure, with a key advantage (compared to litigation in courts) being that disputes should remain confidential. However, in 2024, some collaboration disputes made their way into the public domain. On the branding side, we saw the continued trials and tribulations of the dispute between Kanye West and Adidas over their "Yeezy" brand collaboration. It is critical in collaboration agreements to prepare for the worst. The parties and their advisers should consider all potential outcomes at the earliest stage, both the successful ones (on how to share the gains), and also the unsuccessful ones (on how to share the losses), as well as risk and information sharing throughout the collaboration.
As well as adopting collaborations over acquisitions due to their innate advantages, parties may be driven towards collaborations over acquisitions due to other external factors or constraints in 2025, such as foreign direct investment rules, competition law and taxation.
We expect the changing geopolitical landscape will continue to bring new challenges and opportunities to technology collaborations. The full effects of the Trump administration's policies on IP collaborations between the US and jurisdictions worldwide remain to be seen, and will vary depending on jurisdiction and sector.
Looking ahead, we expect parties to focus increasingly on collaborations in order to develop novel technologies, as an alternative to technology acquisitions. When doing so, in our view, it is most critical for the parties to be clear on their objectives at the outset, and these should be clearly laid out in advance in the documentation - in particular the IP they are contributing to the collaboration (which should be appropriately safe-guarded).
The value of collaborations should not be under-estimated, with a significant number of collaborations in 2024 valued at over $1 billion. Whilst collaborations can be more complex to negotiate compared to technology acquisitions, the opportunities for innovation can be much more profound. We expect a strong 2025 for technology collaborations.
The contents of this publication are for reference purposes only and may not be current as at the date of accessing this publication. They do not constitute legal advice and should not be relied upon as such. Specific legal advice about your specific circumstances should always be sought separately before taking any action based on this publication.
© Herbert Smith Freehills 2025
We’ll send you the latest insights and briefings tailored to your needs